Loading document…
From: Richard Kahn ‹ > Subject: Avalanche Bio chief resigns abruptly Sent Thursday, July 23, 2015 8:50:01 PM To: Jeffrey E." leevacationegmail.com> Avalanche Bio chief resigns abruptly Jul 23 2015, 16:45 ET I About: \' alanche Biotechnologies (AAVL) I By: Douglas W. House, SA News Editor II • Avalanche Biotechnologics (NASDAQ:AAVL) CEO Thomas Chalberg, Ph.D., resigns effective today. The BOD appoints SVP of Business Operations Hans Hull as interim CEO and President. A search for a permanent successor is underway. • Shares are off a fraction after hours. Richard Kahn I IBRK Associates Inc. EFTA_R1_000351378 EFTA01743919
Suggest a category
Misclassified? Pick a better fit.